Hemophilia B is a severe X-linked bleeding diathesis caused by the absence of functional blood coagulation factor IX, and is an excellent candidate for treatment of a genetic disease by gene therapy.

For many years gene therapy researchers have striven to develop a cure for haemophilia A. This bleeding disorder is an X-linked recessive disease resulting from a deficiency in factor VIII (FVIII) ...